The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 08, 2020
Filed:
Feb. 03, 2017
Applicants:
Academia Sinica, Taipei, TW;
National Taiwan University, Taipei, TW;
Inventors:
Chi-Huey Wong, Rancho Santa Fe, CA (US);
Pan-Chyr Yang, Taipei, TW;
Jim-Min Fang, Taipei, TW;
Szu-Hua Pan, Taipei, TW;
Ting-Jen R. Cheng, New Taipei, TW;
Ling-Wei Li, Taipei, TW;
Assignees:
Academia Sinica, Taipei, TW;
National Taiwan University, Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 473/00 (2006.01); A61K 31/522 (2006.01); A61K 45/06 (2006.01); A61K 31/337 (2006.01); A61K 31/52 (2006.01); A61K 31/506 (2006.01); A61K 31/502 (2006.01); A61K 31/167 (2006.01); A61K 31/454 (2006.01); A61K 38/05 (2006.01); A61K 31/517 (2006.01); A61K 31/4025 (2006.01); A61K 31/5377 (2006.01); A61K 31/69 (2006.01); A61K 31/44 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/522 (2013.01); A61K 31/167 (2013.01); A61K 31/337 (2013.01); A61K 31/4025 (2013.01); A61K 31/44 (2013.01); A61K 31/454 (2013.01); A61K 31/502 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/52 (2013.01); A61K 31/5377 (2013.01); A61K 31/69 (2013.01); A61K 35/00 (2013.01); A61K 38/05 (2013.01); A61K 45/06 (2013.01); C07D 473/00 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present disclosure provides compounds of Formulas (I') and (I), and pharmaceutically acceptable salts thereof. The compounds described herein may be useful in treating and/or preventing proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, and uses thereof for treating proliferative diseases.